[Federal Register Volume 63, Number 38 (Thursday, February 26, 1998)]
[Notices]
[Pages 9794-9795]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-4964]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Vaccines and Related Biological Products Advisory Committee; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Vaccines and Related Biological Products 
Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA regulatory issues.
    Date and Time: The meeting will be held on March 23, 1998, 7:45 
a.m. to 6:20 p.m.
    Location: Ramada Inn, Embassy Ballroom, 8400 Wisconsin Ave., 
Bethesda, MD.
    Contact Person: Nancy T. Cherry or Denise H. Royster, Center for 
Biologics Evaluation and Research (HFM-21), Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12391. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: The committee will: (1) Discuss scientific and ethical 
considerations of a human challenge model using virulent Salmonella 
typhi bacteria; (2) complete recommendations pertaining to the 
influenza virus vaccine formulation for 1998 and 1999; and (3) hear 
short briefings on research programs in the Laboratories of DNA 
Viruses, Hepatitis Viruses, and Bacterial Polysaccharides.

[[Page 9795]]

    Procedure: On March 23, 1998, from 7:45 a.m. to 4:50 p.m., the 
meeting is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the committee. Written submissions may be made to the contact person by 
March 16, 1998. Oral presentations from the public will be scheduled 
between approximately 8 a.m. to 8:15 a.m. and between approximately 
3:30 p.m. to 4:15 p.m. Time allotted for each presentation may be 
limited. Those desiring to make formal oral presentations should notify 
the contact person before March 16, 1998, and submit a brief statement 
of the general nature of the evidence or arguments they wish to 
present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Closed Committee Deliberations: On March 23, 1998, from 4:50 p.m. 
to 6:20 p.m., the meeting will be closed to review data of a personal 
nature where disclosure would constitute a clearly unwarranted invasion 
of personal privacy (5 U.S.C. 552b(c)(6)). This portion of the meeting 
will be closed to permit discussion of this information.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: February 20, 1998.
Michael A. Friedman,
Deputy Commissioner of Operations.
[FR Doc. 98-4964 Filed 2-25-98; 8:45 am]
BILLING CODE 4160-01-F